Invention Grant
- Patent Title: Macrocyclic sulfondiimine compounds
-
Application No.: US15764283Application Date: 2016-09-26
-
Publication No.: US10717749B2Publication Date: 2020-07-21
- Inventor: Ulrich Lücking , Jens Geisler , Daniel Hog , Arne Scholz , Kirstin Petersen , Philip Lienau , Christian Stegmann , Dorothee Andres , Kunzeng Zheng , Ping Gao , Gang Chen , Jiajun Xi , Simon Anthony Herbert , Gerhard Siemeister , Nicolas Werbeck
- Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
- Applicant Address: DE Berlin
- Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
- Current Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
- Current Assignee Address: DE Berlin
- Agency: Morrison & Foerster, LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@3ed938a6
- International Application: PCT/EP2016/072795 WO 20160926
- International Announcement: WO2017/055196 WO 20170406
- Main IPC: C07D498/08
- IPC: C07D498/08 ; C07D498/18 ; A61K31/519 ; C07D498/14 ; C07D498/04 ; A61K31/4375 ; A61K31/444 ; A61K31/505 ; A61K45/06 ; A61P35/00
Abstract:
The present invention relates to novel macrocyclic sulfondiimine compounds of general formula (I) as described and defined herein, and methods for their preparation, their use for the treatment and/or prophylaxis of disorders, in particular of hyper-proliferative disorders and/or virally induced infectious diseases and/or of cardiovascular diseases. The invention further relates to intermediate compounds useful in the preparation of said compounds of general formula (I).
Public/Granted literature
- US20180273548A1 NOVEL MACROCYCLIC SULFONDIIMINE COMPOUNDS Public/Granted day:2018-09-27
Information query
